Randomised, multi-center, double-blind, placebo-controlled, parallel group, phase III clinical study to evaluate the efficacy and safety of intrathecally administered rugonersen in pediatric and adult participants with Angelman syndrome. (OHB-724-301 (BEACON))
Principal Investigator
Prof Laurent Servais
Contact us
Email: childrensresearch@ouh.nhs.uk
IRAS number
1013427